Jim Cramer on Abbott Laboratories (ABT): “This Verdict Is an Outrage” – Wall Street Agrees?
His fears were that Abbott (NYSE:ABT) might pull the product entirely rather than risk further lawsuits—just like Johnson & ...
Jim Cramer on Bristol Myers (BMY): “Knocking It Out of the Park” – Is the Comeback Legit?
Bristol-Myers Squibb Company (NYSE:BMY) had been left for dead on Wall Street, plagued by years of missed earnings and patent ...
Jim Cramer on Intel (INTC): ‘Doing Worse, But They’re CPUs. And It’s A Product Glitch So To Speak’
We recently compiled a list of the Jim Cramer Discusses These 9 Stocks & US AI GPU Advantages. In this article, we are going to take a look at where Intel Corporation (NASDAQ:INTC) stands against the ...
TheStreet.com14h
Jim Cramer
A Wall Street veteran resets his Microsoft forecast.